Arvinas Inc

NASDAQ:ARVN   3:59:54 PM EDT
103.85
+9.80 (+10.42%)
Strategic Combinations, Equity Financing / Related

Arvinas, Pfizer Announce Collaboration To Develop, Commercialize Protac Protein Degrader ARV-471

Published: 07/22/2021 11:09 GMT
Arvinas Inc (ARVN) - Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize Protac® Protein Degrader Arv-471.
Arvinas Inc - Arvinas to Receive $650 Million in an Upfront Payment.
Arvinas Inc - Arvinas to Receive Potential $1.4 Billion in Milestone Payments.
Arvinas Inc - Profits and Costs to Be Shared 50/50 Worldwide.
Arvinas Inc - Pfizer to Complete a $350 Million Equity Investment in Arvinas.
Arvinas Inc - Pfizer to Receive About 3.5 Million Newly Issued Shares of Arvinas.